Physician profile
Robert Chadband
NPI 1134181431
$2,322.60
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $502 · 2020: $685 · 2021: $773 · 2022: $362.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $469.35 | 2019-2022 | |
| Amgen INC. | $249.40 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $148.25 | 2020-2021 | |
| Lilly USA, LLC | $144.30 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $134.55 | 2019-2020 | |
| Medtronic, INC. | $133.56 | 2021-2022 | |
| Medtronic Minimed, INC. | $117.48 | 2020 | |
| Corcept Therapeutics | $101.07 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $83.89 | 2021-2022 | |
| Abbvie INC. | $69.10 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $59.44 | 2019-2021 | |
| Ibsa Pharma INC. | $53.77 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.89 | 2019-2021 | |
| Grifols USA, LLC | $48.41 | 2021 | |
| Janssen Pharmaceuticals, INC | $38.65 | 2019-2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Opko Pharmaceuticals, LLC | $36.48 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $31.80 | 2022 | |
| Collegium Pharmaceutical, INC. | $27.65 | 2019-2020 | |
| Shire North American Group INC | $26.06 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $24.25 | 2019-2020 | |
| Pharmacosmos Therapeutics INC. | $22.55 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.02 | 2022 | |
| Dexcom, INC. | $19.06 | 2019 | |
| Sobi, INC | $19.06 | 2022 | |
| Novo Nordisk INC | $18.91 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.45 | 2021 | |
| Grt US Holding, INC. | $15.95 | 2020 | |
| Mylan Specialty L.P. | $15.25 | 2021 | |
| Currax Pharmaceuticals LLC | $14.13 | 2021 | |
| Adlon Therapeutics L.P. | $13.74 | 2021 | |
| Glaxosmithkline, LLC. | $13.42 | 2021 | |
| Ironwood Pharmaceuticals, INC | $12.68 | 2019 | |
| Sunovion Pharmaceuticals INC. | $11.25 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Chadband listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.